Society of Gynecologic Oncology Publishes Practice Statement on SCR in Recurrent Ovarian Cancer
January 06, 2022
January 06, 2022
CHICAGO, Illinois, Jan. 6 (TNSJou) -- The Society of Gynecologic Oncology issued the following news release:
"Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement," written by members of the SGO Clinical Practice Committee, has been published in the December 2021 edition of Gynecologic Oncology. This Practice Statement reviews the rationale, background, and contemporary clinical trials evaluating secondary cytoreduction (SCR) for . . .
"Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement," written by members of the SGO Clinical Practice Committee, has been published in the December 2021 edition of Gynecologic Oncology. This Practice Statement reviews the rationale, background, and contemporary clinical trials evaluating secondary cytoreduction (SCR) for . . .